GlaxoSmithKline plc will boost its oncology drug roster by developing and selling HuMax-CD20, a new blood-cancer and rheumatoid arthritis drug discovered by Danish biotech company Genmab AS. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results